Lower Serum Antibodies Against Tau Protein and Heavy Neurofilament in Alzheimer’s Disease-Reference-Cited by-同舟云学术

Lower Serum Antibodies Against Tau Protein and Heavy Neurofilament in Alzheimer’s Disease

Published:2018-07-03 Issue:3 Volume:64 Page:751-760
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Bartos Ales¹²,Fialová Lenka³,Švarcová Jana⁴

Affiliation:

1. National Institute of Mental Health, Klecany, Czech Republic

2. Charles University, Third Faculty of Medicine and University Hospital Kralovske Vinohrady, Department of Neurology, Prague, Czech Republic

3. Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine Charles University and General University Hospital in Prague, Czech Republic

4. Department of Medical Chemistry and Clinical Biochemistry, Motol University Hospital, Prague, Czech Republic

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference61 articles.

1. Antibodies to different isoforms of the heavyneurofilament protein (NF-H) in normal aging and Alzheimer’sdisease.;Soussan;Mol Neurobiol,1994

2. CSF biomarkers for amyloid and tau pathology inAlzheimer’s disease.;Rosenmann;J Mol Neurosci,2012

3. A systematicreview and meta-analysis of CSF neurofilament protein levels asbiomarkers in dementia.;Petzold;Neurodegener Dis,2007

4. Pairedhelical filaments from Alzheimer disease patients containcytoskeletal components.;Perry;Proc Natl Acad Sci U S A,1985

5. Alterations inneurofilaments and the transformation of the cytoskeleton in smay provide insight into the aberrant neuronal changes of Alzheimer’s disease.;Vickers;Brain Res Bull,2016

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond;Current Neuropharmacology;2024-05

2. Role of Specific Autoantibodies in Neurodegenerative Diseases: Pathogenic Antibodies or Promising Biomarkers for Diagnosis;Antibodies;2023-12-08

3. CMV as a factor in the development of Alzheimer’s disease?;Medical Hypotheses;2023-09

4. Beyond the amyloid hypothesis: how current research implicates autoimmunity in Alzheimer’s disease pathogenesis;Critical Reviews in Clinical Laboratory Sciences;2023-03-20

5. Blood Neurofilament Light Chain in Different Types of Dementia;Current Alzheimer Research;2023-03